The Past, Present, and Future of Biotech and Longevity with Laura Deming and Will Eden

Joining Erik on this episode are Laura Deming (@laurademing), creator of Longevity Fund, and Will Eden (@williamaeden), entrepreneur in residence with Errik Anderson at Ulysses and formerly of Thiel Capital. They talk about:- The history of biotech and the big trends and companies in the space over the past several decades.- The breakdown of the different areas within biotech.- The new business model in biotech that’s been driven by VCs.- How the public market in biotech companies is impacting the private market- The history of the FDA and how it has evolved over time, including the fact that in the beginning, the FDA only looked at whether a drug was safe, not whether it was effective.- How they would change the regulatory environment if they could wave a magic wand.- Why Laura says that the most effective individuals in biotech have a determinate worldview.- How longevity has emerged over the past several years, and the future of work in the space.Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at villageglobal.vc or get in touch with us on Twitter @villageglobal.Venture Stories is brought to you by Village Global and is hosted by co-founder and partner, Erik Torenberg. Grace Chen is our audio engineer and the show is produced by Brett Bolkowy.